⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for FOLFOXIRI With or Without Intensification for Rectal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: FOLFOXIRI With or Without Intensification for Rectal Cancer

Official Title: A Randomized Study of Neoadjuvant Chemoradiotherapy With or Without Intensification With the FOLFOXIRI Chemo-regimen for High-risk Locally Advanced Rectal Cancer

Study ID: NCT03997435

Conditions

Rectal Cancer

Study Description

Brief Summary: Pathologic complete response rate

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, , Hong Kong

Department of Oncology, Princess Margaret Hospital, Hong Kong, , Hong Kong

The Chinese University of Hong Kong, Hong Kong, , Hong Kong

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: